Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Down-regulation of the liver-specific MAT1A gene, encoding S-adenosylmethionine (SAM) synthesizing isozymes MATI/III, and up-regulation of widely expressed MAT2A, encoding MATII isozyme, known as MAT1A:MAT2A switch, occurs in hepatocellular carcinoma (HCC). Here we found Mat1A:Mat2A switch and low SAM levels, associated with CpG hypermethylation and histone H4 deacetylation of Mat1A promoter, and prevalent CpG hypomethylation and histone H4 acetylation in Mat2A promoter of fast-growing HCC of F344 rats, genetically susceptible to hepatocarcinogenesis. In HCC of genetically resistant BN rats, very low changes in the Mat1A:Mat2A ratio, CpG methylation, and histone H4 acetylation occurred. The highest MAT1A promoter hypermethylation and MAT2A promoter hypomethylation occurred in human HCC with poorer prognosis. Furthermore, levels of AUF1 protein, which destabilizes MAT1A messenger RNA (mRNA), Mat1A-AUF1 ribonucleoprotein, HuR protein, which stabilizes MAT2A mRNA, and Mat2A-HuR ribonucleoprotein sharply increased in F344 and human HCC, and underwent low/no increase in BN HCC. In human HCC, Mat1A:MAT2A expression and MATI/III:MATII activity ratios correlated negatively with cell proliferation and genomic instability, and positively with apoptosis and DNA methylation. Noticeably, the MATI/III:MATII ratio strongly predicted patient survival length. Forced MAT1A overexpression in HepG2 and HuH7 cells led to a rise in the SAM level, decreased cell proliferation, increased apoptosis, down-regulation of Cyclin D1, E2F1, IKK, NF-κB, and antiapoptotic BCL2 and XIAP genes, and up-regulation of BAX and BAK proapoptotic genes. In conclusion, we found for the first time a post-transcriptional regulation of MAT1A and MAT2A by AUF1 and HuR in HCC. Low MATI/III:MATII ratio is a prognostic marker that contributes to determine a phenotype susceptible to HCC and patients' survival. Conclusion: Interference with cell cycle progression and I-kappa B kinase (IKK)/nuclear factor kappa B (NF-κB) signaling contributes to the antiproliferative and proapoptotic effect of high SAM levels in HCC. (HEPATOLOGY 2012;56:165–175)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brennan, C. M., & Steitz*, J. A. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000854 · Cited by 1,095 · cited 1×
“Furthermore, recent work(22) showed Mat1A mRNA decrease in fetal rat liver, associated with an increase in its interaction with AUF1 (AUrich RNA binding factor 1), enhancing messenger RNA (mRNA) decay,(23) and an increase in Mat2A mRNA and its interaction with HuR (Huantigen R), which selectively binds to AUrich eleme…”
BackgroundEpigenetic gene silencing in cancer: the DNA hypermethylome
Esteller, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm018 · Cited by 725 · cited 1×
“Suppression of gene expression is frequently associated with methylated DNA and deacetylated histones, in a dense chromatin structure, whereas active transcription is associated with unmethylated DNA, hyperacetylated histones, in open chromatin.(40) According to recent results,(20) methylation of CCGG at 997 does not…”
BackgroundDetection and interpretation of altered methylation patterns in cancer cells
Ushijima, T. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1571 · Cited by 483
Self-citationConcurrent versus individual binding of HuR and AUF1 to common labile target mRNAs
Lal, A., Mazan‐Mamczarz, K., Kawai, T., Yang, X., Martindale, J. L., & Gorospe, M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600305 · Cited by 461 · cited 1×
“Furthermore, recent work(22) showed Mat1A mRNA decrease in fetal rat liver, associated with an increase in its interaction with AUF1 (AUrich RNA binding factor 1), enhancing messenger RNA (mRNA) decay,(23) and an increase in Mat2A mRNA and its interaction with HuR (Huantigen R), which selectively binds to AUrich eleme…”
BackgroundCalvisi, D. F., Simile, M. M., Ladu, S., Frau, M., Evert, M., Tomasi, M. L., Demartis, M. I., Daino, L., Seddaiu, M. A., Brozzetti, S., et al. (2011) · Hepatology · doi:10.1002/hep.24174 · Cited by 65
Self-citationFrau, M., Ladu, S., Calvisi, D. F., Simile, M. M., Bonelli, P., Daino, L., Tomasi, M. L., Seddaiu, M. A., Feo, F., & Pascale, R. M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.031 · Cited by 60
Self-citation
Cited by
Relationship Between Methylome and Transcriptome in Patients With Nonalcoholic Fatty Liver Disease
Murphy, S. K., Yang, H., Moylan, C. A., Pang, H., Dellinger, A., Abdelmalek, M. F., Garrett, M. E., Ashley–Koch, A., Suzuki, A., Tillmann, H. L., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.047 · Cited by 391
Zhang, L., Yang, F., Yuan, J.-H., Yuan, S.-X., Zhou, W.-P., Huo, X.-S., Xu, D., Bi, H.-S., Wang, F., & Sun, S.-H. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs381 · Cited by 334
Frau, M., Feo, F., & Pascale, R. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.031 · Cited by 179
Self-citationLo, T.-F., Tsai, W.-C., & Chen, S.-T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075628 · Cited by 122
Acetylation of MAT IIα represses tumour cell growth and is decreased in human hepatocellular cancer
Yang, H.-B., Xu, Y.-Y., Zhao, X.-N., Zou, S.-W., Zhang, Y., Zhang, M., Li, J.-T., Ren, F., Wang, L.-Y., & Lei, Q.-Y. (2015) · Nature Communications · doi:10.1038/ncomms7973 · Cited by 65
One-Carbon Metabolism in Liver Health and Disease
Mato, J. M., Martínez-Chantar, M. L., Noureddin, M., & Lu, S. C. (2017) · Liver Pathophysiology · doi:10.1016/b978-0-12-804274-8.00054-0 · Cited by 12
Metadata
- Authors
- Frau, M., Tomasi, M. L., Simile, M. M., Demartis, M. I., Salis, F., Latte, G., Calvisi, D. F., Seddaiu, M. A., Daino, L., Feo, C. F., Brozzetti, S., Solinas, G., Yamashita, S., Ushijima, T., Feo, F., & Pascale, R. M.
- Venue
- Hepatology
- Published
- 2012-07
- Volume
- 56
- Issue
- 1
- Pages
- 165-175
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2057553963
- Cited by
- 87
- References
- 6
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.